Sentences with phrase «synthetic vaccines for»

Not exact matches

Raising organic meat is far more than just making sure animals are free ranging and grass fed, it's equally about producing cattle without synthetic growth hormones, limiting vaccine use, not using routine antibiotics, breeding using natural methods, stress free weaning that allows for the ethological needs of mothers and young, access at all times to unfiltered sunlight and not using electric prodders as a routine management method.

Beyond the payroll tax and charitable donation programs, Cuomo offered up ideas to reduce traffic congestion in New York City, expand availability of flu vaccines for children, impose restrictions on sex offenders, provide funding for an early voting program, ban synthetic marijuana sales and target physicians who engage in medical misconduct.

Maldonado and Almeida have each studied Chagas disease for more than 25 years and recently received a patent for the first synthetic Chagas vaccine.

Synthetic DNA vaccine technology has many advantages over older technologies for vaccine production.

Using a novel synthetic platform for creating vaccines originally developed in the laboratory of David Weiner, PhD, a professor of Pathology and Laboratory Medicine from the Perelman School of Medicine at the University of Pennsylvania, a team led by his colleagues at the Johns Hopkins University School of Medicine, has successfully eradicated precancerous cervical lesions in nearly half of the women who received the investigational vaccine in a clinical trial.

Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones, or bath salts.

«Niederberger and colleagues have designed a new kind of allergy vaccine which consists of synthetic fragments of allergen proteins, instead of natural extracts of allergen that have been the mainstay of allergy vaccines for over 100 years.

Most recently, the foundation awarded a $ 1.4 million grant to the Wistar Institute in Philadelphia to create a synthetic DNA - based vaccine for malaria.

Although it may be some years before synthetic vaccines are tested in humans, this is an exciting proof - of - concept study which may pave the way for the development of temperature - stable and orally - administered vaccines.

According to Craig Venter, especially famous for his first «synthetic» bacterial cell, the production of seed stocks for flu vaccines could be the first field of application for synthetic genome biology.

Sept. 12, 2017 - A multidisciplinary scientific team at Lawrence Livermore National Laboratory (LLNL) has made significant advances in developing a vaccine for chlamydia using synthetic biology, sponsored by a two - year National Institutes of Health (NIH) grant.

The Wistar Institute was awarded a $ 1,494,972 grant by the Bill & Melinda Gates Foundation to advance a DNA - based vaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Revaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer ReVaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Research.

She has worked in vaccinology for 40 years, and has contributed to the development of synthetic adjuvants and peptidic vaccines and of several innovative delivery systems and cancer vaccines.

PHILADELPHIA - Using a novel synthetic platform for creating vaccines originally developed in the laboratory of David Weiner, PhD, a professor of Pathology and Laboratory Medicine from the Perelman School of Medicine at the University of Pennsylvania, a team led by his colleagues at the Johns Hopkins University School of Medicine, has successfully eradicated precancerous cervical lesions in nearly half of the women who received the investigational vaccine in a clinical trial.